nabu.science
MethodologyAboutContact

 

Reliability concern: This paper was retracted on 2023-05-24. See notice: 10.1155/2023/9872503.

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-C01DF378·Framework v5.0·Pipeline v0.4·Evaluated 01 Jun 2026·OECD: 3.2 Clinical medicine·Subfield: Biomedical Engineering·Basis: Full text·Type: Laboratory experiment

The Correlation between Targeted Contrast-Enhanced Ultrasound Imaging and Tumor Neovascularization of Ovarian Cancer Xenografts in Nude Mice.

Hu et al.Hu, Zeng, Su et al.·2021·Journal of healthcare engineering·10.1155/2021/5553649 ↗

In brief

A preclinical correlation study linking targeted ultrasound to ovarian cancer neovascularization, fatally undermined by an unidentified targeting antibody and pervasive text integrity issues.

ReliabilityConcerns4 of 4 checks completeRead the 3 entries ↓
Abstract

In order to explore the correlation between targeted contrast-enhanced ultrasound imaging and tumor neovascularization of ovarian cancer xenografts in nude mice, a total of 49 nude mice were selected and randomly divided into 1-week group, 2-week group, 3-week group, 4-week group, 5-week group, 6-week group, and 7-week group according to their ovarian cancer xenografts' growth time, with 7 ovarian cancer xenografts in each group. After preparing antibody-carrying targeted contrast agent, each group of xenografts performed normal and targeted contrast ultrasound examinations to obtain peak intensity, time to peak, and other imaging parameters; then, those ovarian cancer xenografts were sacrificed for pathological analysis: the neovascular density and antibody expression of the cancer xenografts at different stages were observed and counted, and the correlation between targeted contrast-enhanced ultrasound parameters and tumor neovascular densities of the ovarian cancer xenografts was analyzed. The results show that the peak intensities of targeted contrast ultrasound imaging are greater than that of ordinary ultrasound imaging in the 2-, 3-, 4-, and 5-week groups with statistically significant differences (P < 0.05); the time to peak of targeted contrast ultrasound imaging is shorter than that of ordinary ultrasound imaging in the 2-, 3-, 4-, and 5-week groups with statistically significant differences (P < 0.05); there is a positive correlation between the peak intensities of targeted contrast ultrasound imaging and tumor neovascular densities of the ovarian cancer xenografts in the 2-, 3-, and 4-week group (r 2 = 0.645, r 3 = 0.668, and r 4 = 0.693, P < 0.05); there is a negative correlation between the time to peak of targeted contrast ultrasound imaging and tumor neovascular densities of the ovarian cancer xenografts in the 2-, 3-, and 4-week groups (r 2 = -0.669, r 3 = -0.692, and r 4 = -0.704, P < 0.05). Therefore, the targeted contrast-enhanced ultrasound imaging parameters have a certain correlation with tumor neovascular density of ovarian cancer xenografts in nude mice and this correlation is more significant in the early stage of ovarian cancer; hence, targeted contrast-enhanced ultrasound imaging may provide a new method, new idea, and new basis for the diagnosis of early ovarian cancer.

Strengths · Limitations

Strengths

#methodological rigour

Appropriate time-series paired imaging design

The study's use of seven time-point groups with paired ordinary versus targeted CEUS measurements within the same animals, correlated against histological endpoints, is a conceptually sound design for characterizing the temporal relationship between imaging parameters and neovascular density.

↳ Sections 2.1, 2.4

#contribution

Dual converging imaging parameters measured

Both peak intensity and time to peak were measured and correlated with neovascular density, providing two independent imaging parameters that show consistent directional findings (positive and negative correlations, respectively) in weeks 2–4.

↳ Abstract; Table 4; Figures 4, 6, 7

#reporting

Appropriately hedged conclusions

The conclusions use qualifying language ('may provide a new method') rather than claiming clinical diagnostic utility directly, which is proportionate to the animal model evidence presented.

↳ Section 6 (Conclusions)

Limitations

#methodological rigour

Central targeting antibody never identified

The antibody used as the targeting agent — the central experimental variable — is referred to only as 'antibody' or 'anti-mouse monoclonal antibody' throughout the manuscript. No name, clone, catalog number, or supplier is provided, making the study irreproducible and the specificity claim unverifiable.

↳ Sections 2.1, 2.3, throughout manuscript

#reporting

Pervasive off-topic text contamination

The Results and Discussion sections contain extensive passages on liposomes, nuclide prepositioning, circadian clock genes, chemotherapy, and apoptosis that are unrelated to the stated correlational study, raising concerns about manuscript assembly integrity.

↳ Sections 3.1, 3.2, 4.1, 5.1, 5.2

#methodological rigour

Incomplete statistical and methodological reporting

The correlation analysis method (Pearson vs. Spearman) is not specified, no confidence intervals are reported, no power calculation justifies the n=7 per group design, and correlations for weeks 1, 5, 6, and 7 are not formally reported despite data being collected.

↳ Section 2.7; Abstract; Table 4

Does this match your read? Add your assessment ↓

Withdrawn — shown for reference only

Nabu Commentary

The three independent evaluations converged on a consistent assessment: this is a preclinical study with a reasonable conceptual design but severe reporting deficiencies that undermine its scientific value. The most critical gap is the failure to identify the targeting antibody anywhere in the manuscript — an omission that renders the central experimental variable unknown and the study unreproducible. The pervasive off-topic text in Sections 3–6, covering subjects from liposome drug delivery to circadian clock genes, raised concerns about the manuscript's assembly and editorial integrity. Statistical reporting gaps, including unspecified correlation methods, absent confidence intervals, and selective reporting of only weeks 2–4 correlations, further limit the evidentiary weight of the findings. The modest correlation coefficients (r = 0.645–0.704) in the reported weeks, while plausible, cannot be properly evaluated without knowing the targeting agent or the full statistical context.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.0±0.2

Contribution
2.2

The study reports a correlational finding between targeted CEUS parameters and neovascular density in a mouse ovarian cancer xenograft model, which is incremental rather than transformative. The failure to identify the targeting antibody by name, clone, or source prevents evaluation of the specific advance and makes the contribution unverifiable and unreproducible.

Abstract; Sections 2.1, 2.3

may provide a new method, new idea, and new basis for the diagnosis of early ovarian cancer

Methodological Rigour
1.9

The time-series xenograft design with paired ordinary vs. targeted CEUS comparisons is conceptually appropriate, but execution reporting is severely deficient. The targeting antibody is never identified, correlation analysis method is unspecified, no power calculation is reported, blinding is not mentioned, and correlations for weeks 1, 5, 6, and 7 are not formally reported despite data collection.

Sections 2.3, 2.6, 2.7; Table 4

anti-mouse monoclonal antibody

Reporting
2.0

The manuscript follows a recognizable IMRAD structure and the core correlational argument is traceable, but clarity is substantially impaired by extensive off-topic passages on liposomes, nuclide prepositioning, circadian clock genes, and chemotherapy that are unrelated to the stated study. Imprecise terminology throughout further undermines readability.

Sections 3.1, 3.2, 4.1, 5.1, 5.2
Positioning
2.1

The paper cites 22 references and provides general background on CEUS and ovarian cancer, but engagement with directly relevant prior work is superficial. No specific comparison with existing studies using similar xenograft models or targeted contrast agents is provided, and the limitations discussion is brief and incomplete.

Introduction; Sections 5.1, 5.2

Reliability

Concerns4 of 4 checks


Internal CoherenceNoted

The core correlational findings are internally consistent between abstract and results, but the manuscript contains extensive off-topic text passages (liposomes, nuclide prepositioning, circadian clock genes in Sections 4.1, 5.1, 5.2), a duplicated sentence between Sections 2.6 and 3.1, and therapeutic intervention language embedded in what is described as an observational study.

Research ConductNoted

Ethics approval is declared in general terms but no committee name or approval number is provided. No conflict of interest statement is present. The targeting antibody — the central experimental variable — is never identified by name, clone, or source, which is a critical omission for reproducibility.

Flags: 2 declared / 5 total

Reference IntegrityClean

All 21 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordConcern

This paper was retracted on 2023-05-24. See notice: 10.1155/2023/9872503.

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Cancer and neoplasms · Ovarian cancer
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
BeneficiariesMedium
CitationsFWCI 0.4
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The correlation between imaging parameters and neovascularization was demonstrated only in controlled nude-mouse xenograft experiments, not in any human setting.

From the paper
“targeted contrast-enhanced ultrasound imaging may provide a new method, new idea, and new basis for the diagnosis of early ovarian cancer”

The paper names a possible diagnostic use of its findings but does not identify who would act on them or in what specific setting.

Pathway

Radiologists and clinical imaging researchers would develop targeted contrast-enhanced ultrasound into an early diagnostic tool for ovarian cancer patients.

Barrier

The evidence is limited to nude-mouse xenografts, so clinical validation in human patients is required before any diagnostic use.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Three-Dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research

    Wanigasekara, Carroll, Cullen, et al. · 2023 · Clinical medicine

    Primary claim

    The expected results from these protocols confirmed the ability of all these methods to create uniform tumourspheres.

    Tentative
    Evidence Score
    2.9±0.2
    Reliability
    Concerns
  2. High Impact Biomass Valorization for Second Generation Biorefineries in India: Recent Developments and Future Strategies for Sustainable Circular Economy

    Thaha, Ghamari, Jothiprakash, et al. · 2025 · Chemical Engineering

    Evidence Score
    2.7±0.1
    Reliability
    Caveats
  3. Robust clay binder for earth-based concrete

    Daria Ardant, Coralie Brumaud, Arnaud Perrot, et al. · 2023 · Civil engineering

    Primary claim

    We show that the solid volume fraction of clay paste is the key parameter allowing predicting the fresh state properties of the clay binder, whatever the constitutive clay type

    Tentative
    Evidence Score
    3.2±0.2
    Reliability
    Caveats

How the rubric works →